Victory Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.7M | Buy |
|
|||||
|
2025
Q2 | $593K | Sell |
|
|||||
|
2025
Q1 | $2.1M | Buy |
|
|||||
|
2024
Q4 | $1.64M | Sell |
|
|||||
|
2024
Q3 | $13.4M | Sell |
|
|||||
|
2024
Q2 | $22.6M | Buy |
|
|||||
|
2024
Q1 | $22.7M | Buy |
|
|||||
|
2023
Q4 | $24.9M | Sell |
|
|||||
|
2023
Q3 | $35.9M | Buy |
|
|||||
|
2023
Q2 | $7.52M | Sell |
|
|||||
|
2023
Q1 | $21.2M | Buy |
|
|||||
|
2022
Q4 | $2.23M | Buy |
|
|||||
|
2022
Q3 | $1.48M | Buy |
|
|||||
|
2022
Q2 | $936K | Buy |
|
|||||
|
2022
Q1 | $236K | Sell |
|
|||||
|
2021
Q4 | $393K | Buy |
|
|||||
|
2021
Q3 | $325K | Sell |
|
|||||
|
2021
Q2 | $339K | Buy |
|
|||||
|
2021
Q1 | $347K | Sell |
|
|||||
|
2020
Q4 | $73.7M | Sell |
|
|||||
|
2020
Q3 | $54M | Buy |
|
|||||
|
2020
Q2 | $52.9M | Sell |
|
|||||
|
2020
Q1 | $74M | Buy |
|
|||||
|
2019
Q4 | $39.2M | Buy |
|
|||||
|
2019
Q3 | $29.4M | Buy |
|
|||||
|
2019
Q2 | $45.6M | Buy |
|
|||||
|
2019
Q1 | $42.2M | Sell |
|
|||||
|
2018
Q4 | $30.2M | Sell |
|
|||||
|
2018
Q3 | $45.2M | Buy |
|
|||||
|
2018
Q2 | $56.3M | Buy |
|
|||||
|
2018
Q1 | $46M | Buy |
|
|||||
|
2017
Q4 | $38.1M | Buy |
|
|||||
|
2017
Q3 | $37.6M | Sell |
|
|||||
|
2017
Q2 | $44M | Sell |
|
|||||
|
2017
Q1 | $35.4M | Buy |
|
|||||
|
2016
Q4 | $20.3M | Buy |
|
|||||
|
2016
Q3 | $29.8M | Buy |
|